Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.7270
+0.0350 (5.06%)
At close: Sep 9, 2026, 4:00 PM EDT
0.7400
+0.0130 (1.79%)
Pre-market: Sep 10, 2026, 5:24 AM EDT
Standard BioTools Employees
As of December 31, 2025, Standard BioTools had 389 total employees, including 385 full-time and 4 part-time employees. The number of employees decreased by 429 or -52.44% compared to the previous year.
Employees
389
Change (1Y)
-429
Growth (1Y)
-52.44%
Revenue / Employee
$217,473
Profits / Employee
$218,267
Market Cap
285.40M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 389 | -429 | -52.44% | 385 | 4 |
| Dec 31, 2024 | 818 | 279 | 51.76% | 814 | 4 |
| Dec 31, 2023 | 539 | 16 | 3.06% | 534 | 5 |
| Dec 31, 2022 | 523 | -92 | -14.96% | 523 | 0 |
| Dec 31, 2021 | 615 | -12 | -1.91% | 615 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Viemed Healthcare | 1,438 |
| Neuronetics | 658 |
| InfuSystem Holdings | 473 |
| RxSight | 461 |
| Treace Medical Concepts | 450 |
| AVITA Medical | 226 |
| Electromed | 197 |
| Perspective Therapeutics | 166 |
LAB News
- 5 weeks ago - Standard BioTools Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 5 weeks ago - Standard BioTools Earnings release: Q2 2026 - Filings
- 5 weeks ago - Standard BioTools Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Standard BioTools to sell Mass Cytometry business to Multiplex Bio for $10M - TheFly
- 6 weeks ago - Standard BioTools Announces Sale of Mass Cytometry Business and Illumina's Buyout of Contingent Payments to Advance Merger with Treeline Biosciences - GlobeNewsWire
- 7 weeks ago - Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026 - GlobeNewsWire
- 7 weeks ago - Standard BioTools files registration statement for Treeline Biosciences merger - TheFly
- 7 weeks ago - Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction - GlobeNewsWire